Pattern and distribution of myocardial fibrosis in systemic sclerosis - A delayed enhanced magnetic resonance imaging study

被引:167
作者
Tzelepis, George E.
Kelekis, Nikolaos L.
Plastiras, Sotiris C.
Mitseas, Panayiotis
Economopoulos, Nikolaos
Kampolis, Christos
Gialafos, Elias J.
Moyssakis, Ioannis
Moutsopoulos, Haralampos M.
机构
[1] Univ Athens, Sch Med, Dept Pathophysiol, GR-11527 Athens, Greece
[2] Univ Athens, Med Sch & Laiko, Athens, Greece
来源
ARTHRITIS AND RHEUMATISM | 2007年 / 56卷 / 11期
关键词
D O I
10.1002/art.22971
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. To assess the prevalence and pattern of myocardial fibrosis as detected by delayed enhanced magnetic resonance imaging (DE-MRI) in patients with systemic sclerosis (SSc), and to evaluate a possible association between myocardial fibrosis and cardiac arrhythmias. Methods. Forty-one patients with SSc underwent 24-hour Holter monitoring, Doppler echocardiography, and DE-MRI following gadolinium administration. Results. Technically acceptable DE-MRIs were obtained in 36 patients with SSc. Enhancement on DE-MRI, consistent with myocardial fibrosis, was observed in 24 of these patients (66%), and it was invariably midwall with a linear pattern, mostly involving basal and midcavity segments of the left ventricle. The volume of enhancement (total volume percentage index [TVPI]) did not differ between patients with diffuse SSc and those with limited SSc- (mean +/- SD 1.46 +/- 1.73% versus 1.44 +/- 1.77%; P = 0.98). Patients with a long duration ( >= 15 years) of Raynaud's phenomenon had a greater number of enhancing segments (mean +/- SD 6.55 +/- 4.93 versus 2.96 +/- 3.46; P = 0.017) and a greater TVPI (mean +/- SD 2.44 +/- 1.97% versus 1.02 +/- 1.43%; P = 0.02) than those with a duration of Raynaud's phenomenon <15 years. Nineteen patients with SSc (53%) had abnormal Holler study results. Compared with patients with normal Holter study results, those with abnormal results had a greater number of enhancing segments (mean SD 5.4 +/- 4.8 versus 2.5 +/- 2.9; P < 0.05) and a greater TVPI (mean +/- SD 2.1 +/- 1.9% versus 0.8 +/- 1.2%; P < 0.05). Conclusion. DE-MRI can identify myocardial fibrosis in a significant percentage of patients with SSc and may be a useful noninvasive tool for determining cardiac involvement.
引用
收藏
页码:3827 / 3836
页数:10
相关论文
共 50 条
[1]   Diagnostic performance of cardiovascular magnetic resonance in patients with suspected acute myocarditis -: Comparison of different approaches [J].
Abdel-Aty, H ;
Boyé, P ;
Zagrosek, A ;
Wassmuth, R ;
Kumar, A ;
Messroghli, D ;
Bock, P ;
Dietz, R ;
Friedrich, MG ;
Schulz-Menger, J .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 45 (11) :1815-1822
[2]   PRELIMINARY CRITERIA FOR THE CLASSIFICATION OF SYSTEMIC-SCLEROSIS (SCLERODERMA) [J].
不详 .
ARTHRITIS AND RHEUMATISM, 1980, 23 (05) :581-590
[3]   Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy [J].
Assomull, Ravi G. ;
Prasad, Sanjay K. ;
Lyne, Jonathan ;
Smith, Gillian ;
Burman, Elizabeth D. ;
Khan, Mohammed ;
Sheppard, Mary N. ;
Poole-Wilson, Philip A. ;
Pennell, Dudley J. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 48 (10) :1977-1985
[4]  
Blyth KG, 2005, EUR HEART J, V26, P1993, DOI 10.1093/eurheartj/ehi328
[5]   MYOCARDIAL LESIONS OF PROGRESSIVE SYSTEMIC-SCLEROSIS - CAUSE OF CARDIAC DYSFUNCTION [J].
BULKLEY, BH ;
RIDOLFI, RL ;
SALYER, WR ;
HUTCHINS, GM .
CIRCULATION, 1976, 53 (03) :483-490
[6]   ANGINA-PECTORIS, MYOCARDIAL-INFARCTION AND SUDDEN CARDIAC DEATH WITH NORMAL CORONARY-ARTERIES - CLINICOPATHOLOGIC STUDY OF 9 PATIENTS WITH PROGRESSIVE SYSTEMIC-SCLEROSIS [J].
BULKLEY, BH ;
KLACSMANN, PG ;
HUTCHINS, GM .
AMERICAN HEART JOURNAL, 1978, 95 (05) :563-569
[7]   Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart - A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association [J].
Cerqueira, MD ;
Weissman, NJ ;
Dilsizian, V ;
Jacobs, AK ;
Kaul, S ;
Laskey, WK ;
Pennell, DJ ;
Rumberger, JA ;
Ryan, T ;
Verani, MS .
CIRCULATION, 2002, 105 (04) :539-542
[8]   ACUTE MYOCARDITIS IN FULMINANT SYSTEMIC-SCLEROSIS [J].
CLEMSON, BS ;
MILLER, WR ;
LUCK, JC ;
FERISS, JA .
CHEST, 1992, 101 (03) :872-874
[9]   PATHOLOGIC OBSERVATIONS IN SYSTEMIC SCLEROSIS (SCLERODERMA) - A STUDY OF 58 AUTOPSY CASES AND 58 MATCHED CONTROLS [J].
DANGELO, WA ;
FRIES, JF ;
MASI, AT ;
SHULMAN, LE .
AMERICAN JOURNAL OF MEDICINE, 1969, 46 (03) :428-+
[10]   Acute myocarditis associated with adenoviral infection in a patient with scleroderma [J].
Dziadzio, M ;
Giovagnoni, A ;
Pomponio, G ;
Recanatini, A ;
della Costanza, OP ;
Manzin, A ;
Casagrande, W ;
Gabrielli, A .
CLINICAL RHEUMATOLOGY, 2003, 22 (06) :487-490